Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00433732 · ClinicalTrials.gov registry record · Phase 3
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
A Phase 3 study, sponsored by POZEN.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,400
- Enrollment target
NCT00433732: Completed Phase 3 study, sponsored by POZEN.
NCT00433732 is a Phase 3 study that has completed, run by POZEN. The registered enrollment target is 1,400 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00433732, a Phase 3 study, has completed, sponsored by POZEN.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,400 participants
- Enrollment target
Study Summary
To determine the efficacy of the Trexima versus placebo as assessed by pain relief and the incidences of photophobia, phonophobia and nausea at 2 hours after treatment as the primary endpoints.
Interventions
- DRUG sumatriptan
- DRUG naproxen sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2004-08 |
| Est. Completion | 2005-04 |
| Phase | Phase 3 |
What the finished NCT00433732 record still lists
NCT00433732 is an interventional study that assigns participants to a tested intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% higher).
The record links to 0 conditions, and to 2 interventions - of which sumatriptan is the first listed.
NCT00433732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00433732 about?
NCT00433732 is a clinical study titled "To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches". To determine the efficacy of the Trexima versus placebo as assessed by pain relief and the incidences of photophobia, phonophobia and nausea at 2 hours after treatment as the primary endpoints.
What is the current status of trial NCT00433732?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,400 participants. The study started on 2004-08. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00433732?
The interventions under investigation include: sumatriptan (DRUG), naproxen sodium (DRUG).
Who is sponsoring clinical trial NCT00433732?
This trial is sponsored by POZEN, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00433732's enrollment target sits among peer trials
1,400 172nd of 2000 higher than 1,826 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- NCT04250857 · 1,400 participants
HeartStart FRx Defibrillator Event Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia